Evidence map›Paper›PMID 31509428›Full record

ArticleAmerican journal of physiology. Regulatory, integrative and comparative physiology2019

The PVN enhances cardiorespiratory responses to acute hypoxia via input to the nTS.

Brian C Ruyle, Diana Martinez, Cheryl M Heesch, David D Kline, Eileen M Hasser

Open access · bronzeAbstract read
In one paragraph

Article in American journal of physiology. Regulatory, integrative and comparative physiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
1.0field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 36 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Orexin facilitates the ventilatory and behavioral responses of rats to hypoxia.American journal of physiology. Regulatory, integrative and comparative physiology · 2022
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Brian C RuyleDepartment of Biomedical Sciences, University of Missouri, Columbia, Missouri.ORCID 0000-0001-8507-8218
Diana MartinezDepartment of Biomedical Sciences, University of Missouri, Columbia, Missouri.ORCID 0000-0003-0982-4092
Cheryl M HeeschDepartment of Biomedical Sciences, University of Missouri, Columbia, Missouri.ORCID 0000-0002-0042-7253
David D KlineDepartment of Biomedical Sciences, University of Missouri, Columbia, Missouri.ORCID 0000-0003-3269-0184
Eileen M HasserDepartment of Biomedical Sciences, University of Missouri, Columbia, Missouri.ORCID 0000-0003-4552-1021
University of Missouri · US

Funding

Plasticity of nTS Output Neurons In Acute and Chronic HypoxiaR01HL098602 · NHLBI · UNIVERSITY OF MISSOURI-COLUMBIA · PI CUMMINGS, KEVIN JAMES, HASSER, EILEEN M · 2010 to 2023
$8.5M
Role of PVN neuropeptide projections to the nTS in cardiorespiratory controlF31HL140858 · NHLBI · UNIVERSITY OF MISSOURI-COLUMBIA · PI RUYLE, BRIAN C · 2018 to 2019
$47k
NHLBI NIH HHS F31 HL140858NHLBI NIH HHS R01 HL098602
6 · The paper itself

Abstract

Chemoreflex neurocircuitry includes the paraventricular nucleus (PVN), but the role of PVN efferent projections to specific cardiorespiratory nuclei is unclear. We hypothesized that the PVN contributes to cardiorespiratory responses to hypoxia via projections to the nucleus tractus solitarii (nTS). Rats received bilateral PVN microinjections of adeno-associated virus expressing inhibitory designer receptor exclusively activated by designer drug (GiDREADD) or green fluorescent protein (GFP) control. Efficacy of GiDREADD inhibition by the designer receptor exclusively activated by designer drug (DREADD) agonist Compound 21 (C21) was verified in PVN slices; C21 reduced evoked action potential discharge by reducing excitability to injected current in GiDREADD-expressing PVN neurons. We evaluated hypoxic ventilatory responses (plethysmography) and PVN and nTS neuronal activation (cFos immunoreactivity) to 2 h hypoxia (10% O

Indexed as

AnimalsGene Expression RegulationGreen Fluorescent ProteinsHypoxiaLuminescent ProteinsMaleNeuronsOxygenParaventricular Hypothalamic NucleusPiperazinesProto-Oncogene Proteins c-fosRatsRats, Sprague-DawleyRed Fluorescent ProteinSolitary NucleusDREADD agonist compound 21Green Fluorescent ProteinsLuminescent ProteinsOxygenPiperazinesProto-Oncogene Proteins c-fosRed Fluorescent ProteinchemoreflexGiDREADDsympathetic nervous systemventilation

Identifiers

PMID31509428
PMCPMC6962628
OpenAlexW2972494070

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.